B O O K - American College of Rheumatology

3:30 PM
Live Demonstration: Ultrasound Needle Guidance
Eugene Y. Kissin, MD; Boston University; Boston, MA
3:45 PM
Hands on Scanning: Ultrasound Needle Guidance
Faculty
ACR Basic Research Conference –
dAy Two R
8:00 am - 4:30 pm
B402
Admission to the ACR Basic Research Conference requires a
separate registration. See Day One for session overview and
learning objectives.
Session III: Factors Promoting B Cell Autoreactivity
and Protective Immunity
Moderator: Ann Marshak-Rothstein, PhD; University of
Massachusetts Medical School; Worcester, MA
7:00 - 8:00 AM
Continental Breakfast
8:00 AM
Toll Like Receptor Signaling in B cells and Autoimmune Disease
Ann Marshak-Rothstein, PhD; University of Massachusetts
Medical School; Worcester, MA
8:35 AM
Ectopic Lymphoid Tissue
Troy Randall, PhD; University of Rochester; Rochester, NY
9:10 AM
Memory B cells
Inaki Sanz, MD; University of Rochester; Rochester, NY
9:45 - 10:00 AM
Break
Session IV: B Cell Regulation and B Cell Regulators
Moderator: Garnett Kelsoe, PhD; Duke Univeristy Medical
Center; Durham, NC
12:30 PM
B cell Lymphocyte Survival Factors
Michael P. Cancro, PhD; University of Pennsylvania; Philadelphia,
PA
1:05 PM
CD20-focused Therapies - Mechanisms of Action
Martin J. Glennie, PhD; Univesity of Southampton - UK;
Southampton, United Kingdom
1:40 PM
Innate B cells and Natural Antibodies
Gregg J. Silverman, MD; University of California - San Diego; La
Jolla, CA
Session VI: Role of B cells in Autoimmunity: Lessons
from Clinical Trials
Moderator: E. William St.Clair, MD; Duke University Medical
Center; Durham, NC
2:15 PM
Rheumatoid Arthritis
Jonathan C.W. Edwards, MD; University College London; London,
United Kingdom
2:45 PM
Lupus
Jennifer H. Anolik, MD, PhD; University of Rochester; Rochester,
NY
3:15 PM
Sjögren’s Syndrome
E. William St.Clair, MD; Duke University Medical Center; Durham,
NC
3:45 PM
ANCA-associated Vasculitis
John H. Stone, MD, MPH; Massachusetts General Hospital;
Boston, MA
4:15 PM
Wrap-up: Take Home Messages and Future Directions
Betty Diamond, MD; Feinstein Institute for Medical Research;
Manhasset, NY
sunday
10:00 AM
Insights from Immunodeficiencies
Eric Meffre, PhD; Yale University School of Medicine; New
Haven, CT
10:35 AM
Role of Activation-induced Cytidine Deaminase in Tolerance
Garnett Kelsoe, PhD; Duke Univeristy Medical Center; Durham,
NC
ACR Review Course C
8:00 am - 4:00 pm
Hall A3
Admission to the Review Course requires a separate registration.
Moderators: Mary E. Cronin, MD; Medical College of Wisconsin;
Milwaukee, WI
Gregory C. Gardner, MD; University of Washington; Seattle, WA
11:10 AM
Regulatory B cells
Thomas F. Tedder, PhD; Duke University Medical Center;
Durham, NC
11:45 AM - 12:30 PM
Boxed Lunch
Session V: Emerging Concepts in B cell Directed
Therapies
Moderator: Michael P. Cancro, PhD; University of Pennsylvania;
Philadelphia, PA
7:00 - 8:00 AM
Continental Breakfast
8:00 AM
Mixed Connective Tissue Disease is Not Really that Mixed
Virginia D. Steen, MD; Georgetown University Medical Center;
Washington, DC
Talk Overview:
Mixed connective tissue disease was first described in 1972. The
concept has evolved over the years and the current approach to
the diagnosis and treatment in adults and children has changed
as well.
2010 Program Book 23